GSA Capital Partners’s KALA BIO KALA Stock Holding History

GSA Capital Partners’s Portfolio KALA Stock Details KALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$15K	Buy	+1,689	New	+$35.7K	﹤0.01%	1649
2022 Q3	–	Sell	-5	Closed	-$4K	–	1700
2022 Q2	$4K	Sell	5 -6	-55%	-$9.41K	﹤0.01%	1336
2022 Q1	$38K	Buy	+11	New	+$28.8K	0.01%	1346
2021 Q4	–	Sell	-10	Closed	-$66K	–	1601
2021 Q3	$66K	Buy	+10	New	+$86.3K	0.01%	1342
2021 Q2	–	Sell	-9	Closed	-$156K	–	1459
2021 Q1	$156K	Buy	9 +5	+125%	+$97.6K	0.03%	950
2020 Q4	$71K	Buy	+4	New	+$75.3K	0.01%	1124

Other funds holding KALA

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

GSA Capital Partners's KALA Position: Q1 2026 in Review

GSA Capital Partners opened a new position in KALA BIO (KALA) in Q1 2026: 1,689 shares worth $15K. The stake represents ﹤0.01% of the portfolio and ranks #1649 among its holdings. This is a return to the name: GSA Capital Partners previously reported a position in KALA as recently as Q2 2022.

GSA Capital Partners first reported a position in KALA in Q4 2020 and has held it in 6 quarters since. The position peaked at $156K in Q1 2021. 28 funds tracked by Wall St. Rank hold KALA as of Q1 2026.

GSA Capital Partners held 1,689 shares of KALA BIO worth $15K as of Q1 2026.
KALA BIO was a new GSA Capital Partners position in Q1 2026.
KALA BIO made up ﹤0.01% of GSA Capital Partners's portfolio in Q1 2026, its #1649 holding.
GSA Capital Partners first reported a position in KALA BIO in Q4 2020 and has held it in 6 quarters since.
GSA Capital Partners's KALA BIO position peaked at $156K in Q1 2021.
28 funds tracked by Wall St. Rank held KALA BIO as of Q1 2026.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.